Parenteral drug use

Hepatitis C - Parenteral drug use Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Parenteral Drug Use - Hepatitis C [CR9042]

Preliminary questions [10237]

10302

the veteran has been a parenteral drug user at some time.

10303

in the course of the veteran's parenteral drug use, the veteran has shared needles at some time.

10304

in the course of the veteran's parenteral drug use, the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C.

10313

the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, was due to an illness or injury which is identifiable.

10305 — the veteran has established the causal connection between the parenteral drug use and VEA service for the clinical onset of hepatitis C.

10318 — the veteran has established the causal connection between the parenteral drug use and operational service for the clinical onset of hepatitis C.

or

10307 — the veteran has established the causal connection between the parenteral drug use and eligible service for the clinical onset of hepatitis C.

Clinical onset and operational service [10318]

10314 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to operational service.

Clinical onset and eligible service [10307]

10315 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to eligible service.